Jamie Zigterman, a senior scientific program analyst in NCATS’ Office of the Director, supports program activities in the New Therapeutic Uses branch of the drug development partnership programs. Her work in New Therapeutic Uses has focused on assisting with the planning and execution of a workshop on repurposing off-patent drugs and assisting with applications to program funding opportunities. Prior to joining NCATS in August 2019, Zigterman established the position of lead scientist at a small scientific instrument sales company, where she developed analytical methods and was a troubleshooter for customer challenges. She also worked as an adjunct professor of chemistry at the University of West Florida and as an associate research scientist in the Small Molecule Process and Product Development department at Amgen, Inc.
As a public health researcher, Zigterman spent a month volunteering in Ghana, where she conducted public health outreach to rural villages and schools in the Eastern and Greater Accra regions. This work consisted of rendering minor first aid and testing for communicable and noncommunicable diseases, such as hepatitis B, hypertension and malaria. As a professor, she provided leadership to and mentored teaching assistants and undergraduate students. As a process chemist, Zigterman worked on teams developing molecules for clinical trials through Phase III.
Zigterman received her M.P.H. in global health from The George Washington University in Washington, D.C., and is Certified in Public Health (CPH). She received her M.A. in international relations from The University of Oklahoma and her M.S. in organic chemistry from the University of Notre Dame.
Zigterman’s research interests are focused on global health and global health diplomacy; addressing women’s health issues, such as menstrual hygiene and maternal mortality; and promoting initiatives to enable equality for women internationally.